THANK YOU TO OUR SPONSORS

POSTDOCACCELERATOR &CAREERENRICHMENTTM

GRADS

Presented by

PACE IS A NEW PROGRAM AT UCLA that provides inspiration, career exploration and industry networking for UCLA PostDoc and Graduate Students.

In this initial four part series, leaders from biopharma, venture capital and legal will convey their insight and stories including their choices and lessons learned on the career paths they chose. A focal point will be the growing Los Angeles bioscience ecosystem and exposure to local career options and fellowship programs.

Join us for a complementary lunch, networking and good conversation while you discover the next step in your career path!

FREE EVENT

CNSI AuditoriumLOCATION:

Wednesdays Noon - 2pmFeb 12, March 4, April 1 and May 6

DATES:

HELEN S. KIM Managing DirectorVida Ventures

Helen S. Kim is a managing Director of Vida Ventures, a life sciences focused venture capital fi rm. Ms. Kim has over 27 years of

experience in leadership roles in biotechnology. Most recently, Ms. Kim was a partner at The Column Group. Prior, Ms. Kim served as executive vice president of business development at Kite Pharma, Inc. where she led all business and corporate development initiatives successfully selling Kite Pharma to Gilead in 2017. Previously, Ms. Kim served as strategic advisor of NGM Biopharmaceuticals, Inc. from January 2012 through November, 2014. Ms. Kim served as the chief business offi cer at NGM Biopharmaceuticals, Inc. from August 2009 to January 2012. Prior to NGM, she was the chief executive offi cer and president of Kosan Biosciences where she restructured and repositioned the company prior to successfully selling the company to Bristol-Myers Squibb in 2008.

RAJUL JAIN, MD DirectorVida Ventures

Rajul is a physician-scientist by background and was most recently leading the Development organization at Kite Pharma, a Gilead company where he oversaw a team of approximately 200 people developing engineered cell

therapy products to treat a variety of blood cancers and solid tumors. Rajul joined Kite in 2014 and was instrumental to the company’s growth and success, including the advancement of Yescarta® (axicabtagene ciloleucel) from pre-IND phase through global regulatory approvals.

Previously, Rajul was at Amgen where his last role was Global Development Lead. There he oversaw the development of small molecules and biologics in the oncology and bone health therapeutic areas and was instrumental in advancing the R&D pipeline including regulatory approvals of Xgeva and Prolia.

Rajul completed his BA in chemistry and biochemistry at Rice University, and MD and Internal Medicine internship and residency at UT Southwestern Medical school, where he was a Howard Hughes Fellow. He completed his post-doctoral training in biophysics at Rockefeller University, and fellowship training at MD Anderson Cancer Center, where he was Chief Fellow.

WILL WOOD PartnerGates & Cooper

Dr. Wood received his PhD from UCLA and his law degree from the University of California, Hastings College of the Law. His intellectual property law practice focuses on U.S. and International patent prosecution. His technical emphasis includes chemistry, biotechnology and medical devices.

SPEAKERSFebruary 12, 2020

POSTDOCACCELERATOR &CAREERENRICHMENTTM

GRADS

Presented by